STOCK TITAN
  1. Home
  2. News
  3. SXTC

China SXT Pharmaceuticals Inc - SXTC STOCK NEWS

Welcome to our dedicated news page for China SXT Pharmaceuticals (Ticker: SXTC), a resource for investors and traders seeking the latest updates and insights on China SXT Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect China SXT Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of China SXT Pharmaceuticals's position in the market.

News
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
Rhea-AI Summary
China SXT Pharmaceuticals, Inc. has regained compliance with NASDAQ listing rules after its closing bid price remained at $1.00 per share or greater for 10 consecutive business days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.75%
Tags
none
-
News
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split
Rhea-AI Summary
China SXT Pharmaceuticals announces one-for-twenty-five reverse stock split, effective October 5, 2023, to regain compliance with NASDAQ listing requirements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2400%
Tags
none
-
News
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.33%
Tags
none
News
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
none
-
News
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.56%
Tags
none
-
News
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
News
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.48%
Tags
offering
-
News
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.48%
Tags
offering
-
News
China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-58.74%
Tags
offering
News
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
offering
Stock SXTC logo
China SXT Pharmaceuticals Inc

Nasdaq:SXTC

SXTC Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

SXTC Stock Data

791.75k
581.58k
22.01%
1.62%
4.64%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
British Virgin Islands
Po Box 905

About SXTC

china sxt pharmaceuticals, inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional chinese medicine piece tablets (tcmp) in china. it offers advanced, fine, and regular tcmp products, such as chenxiang, sanqifen, hongqi, sumu, jiangxiang, cuyanhusuo, xiatianwu, luxuejing, xuejie, chaosuanzaoren, hongqumi, chuanbeimu, huangshukuihua, wuweizi, dingxiang, renshen, qingguo, juemingzi, and sharen. the company provides its products under the suxuantang, hui chun tang, and tong ren tang brands. as of may 2, 2020, it served 116 pharmaceutical companies, 56 pharmacies, and 76 hospitals. the company was founded in 2005 and is based in taizhou, china.